STRATA Skin Sciences to Participate in Upcoming Investor Conferences
HORSHAM, Pa. , Sept. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in two
STRATA Skin Sciences Reports Second Quarter 2021 Financial Results
HORSHAM, Pa. , Aug. 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended
STRATA Skin Sciences Announces Acquisition of the U.S. Dermatology Business of Ra Medical Systems
Positions STRATA as the predominant provider of excimer laser treatments to address the $6 billion U.S. market for the treatment of chronic skin diseases Delivers added long-term recurring revenue growth potential and prospective customer base Increases competitive positioning with more than 400
STRATA Skin Sciences to Report Second Quarter 2021 Financial Results on August 16, 2021
HORSHAM, Pa. , Aug. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it
STRATA Skin Sciences Announces Appointment of New VP of Marketing
HORSHAM, Pa. , Aug. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the
STRATA Skin Sciences to Participate in the Oppenheimer MedTech, Tools & Diagnostics Summit
HORSHAM, Pa. , May 18, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the
STRATA Skin Sciences Reports First Quarter 2021 Financial Results
HORSHAM, Pa. , May 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended
STRATA Skin Sciences to Report First Quarter 2021 Financial Results on May 12, 2021
HORSHAM, Pa. , April 28, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it
STRATA Skin Sciences Appoints William D. Humphries to Its Board of Directors
HORSHAM, Pa. , April 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of William D.
STRATA Skin Sciences Reports Fourth Quarter and Full Year 2020 Financial Results
HORSHAM, Pa. , March 24, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial